L F Erdile

Summary

Publications

  1. ncbi CD40 activation enhances the magnitude of cellular immune responses against p53 but not the avidity of the effectors
    L F Erdile
    Virogenetics Aventis Pasteur, Troy, NY 12180, USA
    Cancer Immunol Immunother 49:410-6. 2000
  2. ncbi Whole cell ELISA for detection of tumor antigen expression in tumor samples
    L F Erdile
    AVAX Technologies, Inc, Rensselaer, NY, USA
    J Immunol Methods 258:47-53. 2001

Collaborators

Detail Information

Publications2

  1. ncbi CD40 activation enhances the magnitude of cellular immune responses against p53 but not the avidity of the effectors
    L F Erdile
    Virogenetics Aventis Pasteur, Troy, NY 12180, USA
    Cancer Immunol Immunother 49:410-6. 2000
    ..The implications of this work for cancer immunotherapy based on specific responses directed against tumor-associated antigens are discussed...
  2. ncbi Whole cell ELISA for detection of tumor antigen expression in tumor samples
    L F Erdile
    AVAX Technologies, Inc, Rensselaer, NY, USA
    J Immunol Methods 258:47-53. 2001
    ..It should be adaptable to other types of cancer where tumor antigens have been identified and good antibodies are available...